EXACT Sciences Corp. Hits New 52-Week High at $104.00

EXACT Sciences Corp., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 104.00 on March 17, 2026. This achievement marks a remarkable performance over the past year, with the stock appreciating by 142.34%, significantly outpacing the S&P 500's growth of 18.34% during the same period. The company's market capitalization stands at approximately USD 19,824 million, reflecting its solid position within the industry. Despite being a loss-making entity, the stock's performance metrics indicate a notable upward trend. The debt-to-equity ratio is at 0.58, suggesting a manageable level of debt relative to equity. However, the return on equity is currently at -6.55%, indicating challenges in generating profit from shareholders' equity. EXACT Sciences Corp. has not declared any dividends, maintaining a dividend yield of 0.00%. The price-to-book ratio is reported at 8.26, which may reflect investor sentiment regarding the company's growth prospects. Overall, the recent price movement highlights the stock's dynamic activity within the market.